Search Results 951-960 of 17744 for corticosteroid

1. SMAC Mimetic LCL161 Alone or With Cyclophosphamide in Treating Patients With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

   Use of more than low dose corticosteroids ... Joint injections (e.g. arthritis) Doses of corticosteroid should be stable for at least 7 days prior to registration.

2. A Phase 1-2 Dose-Escalation and Cohort-Expansion Study of Oral eFT508 in Subjects With Hematological Malignancies - Mayo Clinic

   ... corticosteroids. During study therapy, subjects may use systemic, enteric, topical or enteric corticosteroids as required for treatment-emergent conditions.

3. Esterified estrogens and methyltestosterone (oral route) - Mayo Clinic

   Menopause symptoms occur when the hormone balance changes in the female body. This combination of hormones will relieve the symptoms of menopause by adding more ...

4. In-office arthroscopy for diagnosing knee pathology - Mayo Clinic

   Her diagnosis was inconclusive, and her treatment relied on corticosteroid injections and anti-inflammatory medications to try to control her pain. In ...

5. Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed By Surgery - Mayo Clinic

   ... corticosteroid (for patients with brain metastasis and other indications for corticosteroid use) is acceptable on a low maintenance or tapering dose schedule ...

6. A Study of Niraparib Combined with Pembrolizumab (MK-3475) in Patients who have Triple-Negative Breast Cancer or Ovarian Cancer - Mayo Clinic

   ... corticosteroids, or immunosuppressive drugs). ... Replacement therapy (eg, thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or ...

7. A Study to Evaluate HKI-272 and Capecitabine for HER2-Positive Breast Cancer and Brain Metastases - Mayo Clinic

   No increase in corticosteroid dose in the week prior to baseline brain imaging. Age ≥ 18 years old. Eastern Cooperative Oncology Group (ECOG) performance ...

8. A Study to Test the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) with One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors - Mayo Clinic

   ... corticosteroids are eligible. Patients who have evidence of active or acute diverticulitis, intra-abdominal abscess, and GI obstruction, within 12 months ...

9. Publications - C. Burcin Taner, M.D. - Mayo Clinic

   Antithymocyte Globulin Use for Corticosteroid Nonresponsive Rejection After Liver Transplantation. Transplant Proc. 2018 Dec; 50 (10):3606-3614 Epub 2018 ...

10. Phase II Study to Assess AFM13 in Patients With R/R CD30-positive T-cell Lymphoma or Transformed Mycosis Fungoides - Mayo Clinic

    Also, the use of physiologic doses of corticosteroids may be approved after consultation with the Sponsor/Medical Monitor. Any other malignancy known to be ...